Hi DunedinScum / others
it costs a lot of money to set up and run diagnostic centers for the PAP tests, and many parts of the world do not have this infrastructure available,
many nations do not pay or greatly limit tests available to woman so we have high incidences of these cancers throughout low and middle income countries,
The research shows Truscreen is as good as and in some cases better than lab tests, while the cost ( including the initial devise cost ) allows a much larger number of tests to be performed.
paper from mexican gov't study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060572/This could well be one of the most undervalued stocks on NZX
so at around these prices I am accumulating,
best regards
fp
